EP1601369A1 - Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressing - Google Patents
Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressingInfo
- Publication number
- EP1601369A1 EP1601369A1 EP03789462A EP03789462A EP1601369A1 EP 1601369 A1 EP1601369 A1 EP 1601369A1 EP 03789462 A EP03789462 A EP 03789462A EP 03789462 A EP03789462 A EP 03789462A EP 1601369 A1 EP1601369 A1 EP 1601369A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- plants
- oils
- unheated
- oil
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 239000003921 oil Substances 0.000 claims abstract description 78
- 241000196324 Embryophyta Species 0.000 claims abstract description 45
- 235000013305 food Nutrition 0.000 claims abstract description 22
- 239000002537 cosmetic Substances 0.000 claims abstract description 18
- 230000000378 dietary effect Effects 0.000 claims abstract description 18
- 235000005911 diet Nutrition 0.000 claims abstract description 17
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 17
- 241001465754 Metazoa Species 0.000 claims abstract description 16
- 241000546193 Clusiaceae Species 0.000 claims abstract description 13
- 241000220217 Sapotaceae Species 0.000 claims abstract description 12
- 241000221017 Euphorbiaceae Species 0.000 claims abstract description 11
- 241000208202 Linaceae Species 0.000 claims abstract description 11
- 241001081833 Myristicaceae Species 0.000 claims abstract description 11
- 241000219929 Onagraceae Species 0.000 claims abstract description 11
- 241000208223 Anacardiaceae Species 0.000 claims abstract description 10
- 241000233788 Arecaceae Species 0.000 claims abstract description 10
- 241001072256 Boraginaceae Species 0.000 claims abstract description 10
- 241000220214 Moringaceae Species 0.000 claims abstract description 9
- 241000220151 Saxifragaceae Species 0.000 claims abstract description 9
- 241000221094 Simmondsiaceae Species 0.000 claims abstract description 9
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 7
- 210000004400 mucous membrane Anatomy 0.000 claims abstract description 5
- 230000000887 hydrating effect Effects 0.000 claims abstract description 4
- 239000002304 perfume Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 16
- -1 perfumery Substances 0.000 claims description 16
- 239000002775 capsule Substances 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 235000015872 dietary supplement Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 5
- 239000003205 fragrance Substances 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000002535 acidifier Substances 0.000 claims description 2
- 239000013543 active substance Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 239000003974 emollient agent Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000003349 gelling agent Substances 0.000 claims description 2
- 150000001261 hydroxy acids Chemical class 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000003605 opacifier Substances 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 235000011837 pasties Nutrition 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229920001296 polysiloxane Polymers 0.000 claims description 2
- 239000003380 propellant Substances 0.000 claims description 2
- 239000003223 protective agent Substances 0.000 claims description 2
- 239000003352 sequestering agent Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 238000009423 ventilation Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims 3
- 239000006185 dispersion Substances 0.000 claims 2
- 239000002610 basifying agent Substances 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 abstract description 6
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 description 60
- 235000015112 vegetable and seed oil Nutrition 0.000 description 12
- 239000007800 oxidant agent Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 230000001590 oxidative effect Effects 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 244000136475 Aleurites moluccana Species 0.000 description 5
- 235000006667 Aleurites moluccana Nutrition 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 239000003642 reactive oxygen metabolite Substances 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 4
- 235000004433 Simmondsia californica Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 244000125300 Argania sideroxylon Species 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 231100000024 genotoxic Toxicity 0.000 description 3
- 230000001738 genotoxic effect Effects 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 230000004792 oxidative damage Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 241000545417 Aleurites Species 0.000 description 2
- 235000016108 Argania sideroxylon Nutrition 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- 235000003198 Cynara Nutrition 0.000 description 2
- 241000208947 Cynara Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000219925 Oenothera Species 0.000 description 2
- 235000004496 Oenothera biennis Nutrition 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- 241000221095 Simmondsia Species 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 229940067596 butylparaben Drugs 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- RYCNUMLMNKHWPZ-SNVBAGLBSA-N 1-acetyl-sn-glycero-3-phosphocholine Chemical compound CC(=O)OC[C@@H](O)COP([O-])(=O)OCC[N+](C)(C)C RYCNUMLMNKHWPZ-SNVBAGLBSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- CZCUIGLMMGPMLC-UHFFFAOYSA-N 5,8-dihydroxy-2-(4-methylpentyl)naphthalene-1,4-dione Chemical compound C1=CC(O)=C2C(=O)C(CCCC(C)C)=CC(=O)C2=C1O CZCUIGLMMGPMLC-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 241000118825 Alkanna tinctoria Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 241000274316 Brochoneura Species 0.000 description 1
- 241000274317 Brochoneura acuminata Species 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 244000179886 Moringa oleifera Species 0.000 description 1
- 235000011347 Moringa oleifera Nutrition 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 235000011483 Ribes Nutrition 0.000 description 1
- 241000220483 Ribes Species 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241001312569 Ribes nigrum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 125000004057 biotinyl group Chemical group [H]N1C(=O)N([H])[C@]2([H])[C@@]([H])(SC([H])([H])[C@]12[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000614 rib Anatomy 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000020354 squash Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940104933 vitamin E 3 mg Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/06—Production of fats or fatty oils from raw materials by pressing
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
Definitions
- the present invention relates to the use of oils from unheated plants or parts of plants, introduced crushed, unheated in the press, chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted without solvent, filtered, in dietary, food, dietary, cosmetic, pharmaceutical (therapeutic) and veterinary compositions.
- the chemical composition of such oils includes molecules that are not very resistant to temperatures exceeding 48 °.
- compositions can be intended for humans and animals.
- the inventor also discovered that the oils extracted from parts of unheated plants or whole plants, introduced crushed unheated in the press, chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae ; Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted without solvent have a lighter color, organoleptic, physicochemical and dietetic properties, food, cosmetics, pharmaceuticals, veterinarians always superior to the oils obtained by cold extraction methods (room temperature), traditional or solvent.
- oils extracted from unheated plants or parts of plants, introduced crushed unheated in the press chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringacea Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, are of superior quality to other oils which have been denatured by preheating the plant part or the plant before grinding or before introduction into the press, extraction being carried out by cold press (room temperature).
- Evidence Improved resistance to rancidity.
- the induction time is 15 h.
- the induction time is 12 hours.
- the molecule must prove that it is active in the cell, a purely chemical test will suggest it but will not demonstrate it.
- the molecule must be effective vis-à-vis a biological oxidant, that is to say an oxidant present in cells. Certain antioxidants have a specific protective activity against certain oxidants.
- TEST3D damage detection system
- the DNA is adsorbed on sensitized wells (diagram, step 1), then incubated with genotoxic agents (step 2).
- the damage caused is recognized and then repaired by the specific protein complexes present in the purified cellular extracts of human origin. Repairing the lesions involves an excision phase of the lesions and then a resynthesis of the DNA fragment or excised bases. During the restorative synthesis step, modified nucleotides are incorporated into the DNA (step 3).
- biotinyl nu eotides are then recognized by an avidin molecule coupled to peroxidase (step 4).
- a chemiluminous substrate for the peroxidase is then added and the signal emitted is measured by a luminometer. (step 5).
- the intensity of the measured signal is a function of the number of lesions repaired on the DNA.
- This system is capable of repairing all types of lesions since the different ways of repairing DNA lesions are present and active in the cell extracts prepared and used for this study. Oxidative damage is therefore recognized in this system.
- the chemiluminous sign is detected using a Lumax2 luminometer. 20 samples were provided to us numbered from CSB 02/01 to CSB 02/20. RESULT For a better visualization of the results, these are expressed as percentage of protection or percentage of inhibition of the formation of oxidative damage on DNA. The value 0% corresponds to the signal for repair of DNA damaged by the oxidant alone. The percentage of protection in the presence of EOR (reactive oxygen species) is calculated as the relative decrease in the damage effect due to radicals
- Nonspecific inhibition (in the absence of reactive oxygen species) of the repair signal can sometimes be observed. This may be due to a direct interaction of the compound with the DNA (desorption of the DNA from the well, non-specific association with the DNA which will mask the damage to the repair proteins ). A control consisting in incubating the agents tested with DNA previously damaged by UVC is therefore added. A decrease in signal under this condition reflects a non-specific inhibition of the compound, independent of its possible properties. antiradicaiaires.
- the specific inhibition or specific protection is equal to the difference between the inhibition in the presence of REE (reactive oxygen species) and the non-specific inhibition. It is a reflection of the anti-free radical activity due to the molecule only.
- RLU Relative Light Unit; arbitrary unit of quantity of light We find in the following two TESTS:
- sample 1 Oil from unheated plants, introduced crushed unheated in the press, extracted cold or at room temperature has better activity than sample 6: Oil from crushed introduced plants heated in the press , extracted cold or at room temperature.
- the levels of type 1 collagen secreted in the incubation medium were measured by an ELISA method after 4 days of culture.
- the regenerating effect of the dermis by the FORAHA hut was evaluated by demonstrating stimulation of collagen synthesis.
- Results we observe in the batch treated with Foraha oil obtained by this process a stimulation of 43% of the synthesis of collagen compared to the control against 32 and 19% for the oils obtained by the other processes.
- the parts of plants or plants are picked, collected, sorted, to be immediately dried.
- Quick cold drying to obtain a humidity level less than 7% can be done by forced ventilation with air whose temperature is below 35 ° and whose humidity is less than or equal to 70%.
- the drying can also be carried out under vacuum, by microwave at low temperature in order to stop the enzymatic reactions.
- the subject of the invention is the use of oils from whole plants and / or from parts of dried plants of the families mentioned, not heated, introduced crushed unheated in the press, cold extracted without solvent in dietetic or food compositions. , food, cosmetic, pharmaceutical (therapeutic) and veterinary supplements for human or animal use.
- the filtration is done by using a centrifuge and / or a cone separator and / or a pocket filter, under vacuum or under nitrogen. This first filtration will be followed by filtration on plate filters, the oil being immediately packaged in barrels under vacuum or under nitrogen.
- the oil may undergo a wintérrsation, a method which allows the components with a high melting point to be crystallized and separated in order to obtain a shiny oil at low temperature,
- oils for each plant, retaining their organoleptic properties and their original chemical compounds.
- the oils thus obtained always have different molecules and more especially molecules sensitive to temperatures above 48 °, to oils obtained according to conventional methods (extraction after preheating of parts of plants or plants before extraction, etc.). These molecules have properties and / or activities of interest for dietetic, food, food supplements, cosmetics, pharmaceutical (therapeutic) and veterinary applications for human or animal use.
- These oils include a lipid fraction and a so-called fraction
- the lipid fraction will vary according to the origins and is mainly composed:
- - neutral lipids among others: monoacylglycerols diacylglycerols, tryacyiglycerols, sterols, ster ⁇ lesters ,. hydrocarbons, - glycotipids among others: monogatactosyldiacyglycerol, sterolglucoside, acvlmonogalàctosyldiaglyerol, monogaladosylmonocyglycerol, - phosphoiipids among others: lysophosphatidylcholine, phosphatylserine, phosphatidic acid, phosphatidylcholine,
- the so-called "unsaponifiable" fraction can include different families of compounds, including: fatty alcohols, acids, hydrocarbons, sterols (campesterol, stigmasterol, ⁇ sitosterol, etc.), methylsterois, triterpene compounds, pro-vitamins A, tocopherols, tocotrienols, xanthophylls, coumarins and or coumarin derivatives, etc.,
- compositions according to the invention can comprise, in addition to oils as defined above, adjuvants chosen in particular from fatty substances, organic solvents, thickeners and / or gelling agents, hydrophilic or lipophilic active agents, softeners, agents moisturizers, antioxidants, emollients, hydroxy acids, opacifiers, polymers, propellants, stabilizers, vitamins, reducers, silicones, perfumes, preservatives, fillers, sequestrants, alkalizing or acidifying agents, UV or other protective agents, dyes or other plant extracts, or any other ingredient usually used in dietetic, food formulations, food supplements, cosmetics (shampoo * lotion, etc.), pharmaceutical (therapeutic) and veterinary human or animal destination.
- the fatty substances can consist of oils, waxes or their mixtures, fatty acids, fatty alcohols, fatty acid esters, mono, di and triglycerides of fatty acids.
- the dietary, food, food, cosmetic, pharmaceutical (therapeutic) and veterinary compositions for human or animal use according to the invention may contain, in addition to these oils defined above, all hydrophilic or lipophilic substances, pigments or nano pigments.
- compositions can be presented in particular in the form of a simple or complex emulsion, such as a cream, a milk, a gel or a gel-cream, powder, stick or other solid forms and optionally be packaged in aerosol and present in the form of foam or spray. It can be prepared in the form of oil-in-water or water-in-oil emulsions. Some of these oils according to the invention can also be incorporated into food emulsions having the consistency of a spread, with fat-soluble, water-soluble vitamins and trace elements and all other authorized substances, for all purposes.
- the cosmetic, dermatological compositions for human or animal use according to the invention generally contain 0.05 to 100% by weight of oil of these oils.
- composition according to the invention can also be a dietary food composition, a food, a food supplement containing from 0.05 to 100% by weight of such oils. It is then presented in the form of capsules, capsules, powder, tablets, gel, pasty compounds etc., and may also contain fat-soluble vitamins such as vitamins A, D and E, K and other oils.
- the inventor further discovered during his research that the oils of certain plants of the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapagaceae, Sapotaceae Simmondsiaceae, extracted according to the invention, had a pham ⁇ acoiogique activity superior to oils of these same families extracted according to other processes. IN VIVO tests have shown the interest of these oils in the treatment of dryness, mucous membranes (eye, etc.) and in the improvement of healing processes.
- the invention therefore also relates to a pharmaceutical (therapeutic) and veterinary composition for human or animal use containing an effective amount of such oils according to the invention, in a non-toxic carrier or excipient.
- Such a composition can be in the form of a capsule, capsule, tablet, injectable liquid, eye drops, ointment, cream, gel, patch, suppository, ovum containing from 0.05% to 100% by weight of these oils.
- It can be administered by oral, local, injectable route, and in general by any natural orifice of the human or animal body, conditioned in normal forms or in progressive release.
- the duration of the treatment is variable according to the severity of the symptoms and can range between 1 and 20 weeks, continuously or discontinuously and can be renewed. Treatment is determined by the doctor.
- oils extracted with traditional methods and / or by solvent very often present risks of irritability of the, dermis of mucous membranes.
- the inventor also discovered that with the oils obtained by this process, these risks are greatly reduced.
- Curcurbitaceae (Squash %), Linaceae (flax %), Onagraceae (evening primrose ..) Saxifragaceae (Cassis ..), Simmondsiaceae (Jojoba %), Myristicaceae (Brochoneura ..), Boraginaceae (Alkanna %), Onagraceae (Evening primrose ..), Sapotaceae (Argan %) and Composeae (Cynara ”). have a neutral flavor and a very light color unlike oils obtained by traditional methods (strong odor , sometimes caramel). They will not have to undergo deodorization treatment, discoloration which distorts the oils.
- the oil of the plants of the families mentioned above and more especially of the families Clusiaceae (Foraha), Euphorbiaceae (Aleurites), Sapotacee (Arganier) have hydrating, restructuring and healing properties of the dermis and mucous membranes superior to the oils obtained by the other processes.
- the oil from plants in the Arecaceae family (palm) contains more pro-vitamin A and derivatives and is of additional interest for dietetic, food, food supplements, cosmetic, pharmaceutical (therapeutic) uses. and veterinarians for human or animal use.
- Oil of Foraha Foraha seed oil (Clusiaceae) 15 Oil of Jojoba Simmondsia chinensis seed oil (family 5 simmondiaceae)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention concerns the use of oils obtained from non-heated parts of plants or whole plants, introduced ground and non-heated in the press, selected among the Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae families, cold-extracted solvent-free and filtered, exhibiting resistance to rancidification, enhanced organoleptic and physico-chemical properties, as anti-oxidant, hydrating, restructuring, cicatrizing agent, in particular for the skin and mucous membranes in dietetic, cosmetic, dermatological, pharmaceutical and veterinary compositions, for humans or animals. The invention also concerns dietetic, food, food complement, cosmetic (including perfume), dermatological, pharmaceutical (therapeutic) and veterinary compositions for humans or animals containing such oils extracted from plants of the above botanical families.
Description
COMPOSITIONS D ' HUILES OBTENUES A PARTIR DE PARTIES DE PLANTES NON CHAUFEES , INTRODUITES NON CHAUFFEES BROYEES DANS LA PRESSE , EXTRAITES PAR PRESSE A FROIDCOMPOSITIONS OF OILS OBTAINED FROM PARTS OF UNHEATED PLANTS, INTRODUCED UNHEATED, GRINDED IN THE PRESS, EXTRACTED BY COLD PRESS
La présente invention a pour objet l'utilisation des huiles provenant des plantes ou parties de plantes non chauffées, introduites broyées, non chauffées dans la presse, choisies parmi les familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites à froid sans solvant, filtrées, dans les compositions diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires. La composition chimique de telles huiles comprend des molécules peu résistantes à des températures dépassant 48°. Ces compositions peuvent être destinées à l'homme comme à l'animal. L'inventeur a également découvert que les huiles extraites de parties de plantes ou de plantes entières non chauffées, introduites broyées non chauffées dans la presse, choisies parmi les familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae; Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites à froid sans solvant ont une couleur plus claire, des propriétés organoleptiques, physicochimiques et des propriétés diététiques, alimentaires,, cosmétiques, pharmaceutiques, vétérinaires toujours supérieures aux huiles obtenues par les méthodes d'extraction à froid (température ambiante), traditionnelles ou par solvant. De manière générale, les huilés extraites des plantes ou parties de plantes non chauffées, introduites broyées non chauffées dans lé presse, choisies parmi les familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, sont de qualité supérieure aux autres huiles qui ont été dénaturées par le préchauffage de la partie de plante ou de la plante avant broyage ou avant l'introduction dans la presse, l'extraction étant effectuée par presse à froid (température ambiante).
Preuve: Amélioration de la résistance au rancissement . Le test RANCIMAT effectué avec l'appareil MESTROHM RANCIMAT à T de100°C avec un débit d'air de 15 l./h. nous a permis de déterminer le temps d'induction . Dans fa famille des Sapotacées, pour l'huile de PArgania spinosa obtenue à partir de plantes introduites non chauffées, extraite par presse à température ambiante (à froid) le temps d'induction est de 15 h. alors que pour l'huile obtenue à partir des mêmes plantes introduites chauffées, extraites par presse à température ambiante (à froid) le temps d'induction est de 12 heures. Nous pouvons en déduire une meilleure résistance au rancissement de l'huile extraite par presse à froid à partir de plantes non chauffées, introduites non chauffée. Cette spécificité, évidemment, aura une influence sur la durée de conservation des produits finis dans les domaines diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale.The present invention relates to the use of oils from unheated plants or parts of plants, introduced crushed, unheated in the press, chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted without solvent, filtered, in dietary, food, dietary, cosmetic, pharmaceutical (therapeutic) and veterinary compositions. The chemical composition of such oils includes molecules that are not very resistant to temperatures exceeding 48 °. These compositions can be intended for humans and animals. The inventor also discovered that the oils extracted from parts of unheated plants or whole plants, introduced crushed unheated in the press, chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae ; Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted without solvent have a lighter color, organoleptic, physicochemical and dietetic properties, food, cosmetics, pharmaceuticals, veterinarians always superior to the oils obtained by cold extraction methods (room temperature), traditional or solvent. In general, the oils extracted from unheated plants or parts of plants, introduced crushed unheated in the press, chosen from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringacea Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, are of superior quality to other oils which have been denatured by preheating the plant part or the plant before grinding or before introduction into the press, extraction being carried out by cold press (room temperature). Evidence: Improved resistance to rancidity. The RANCIMAT test carried out with the MESTROHM RANCIMAT device at T of 100 ° C with an air flow of 15 l./h. allowed us to determine the induction time. In the Sapotaceae family, for the oil of Argania spinosa obtained from unheated introduced plants, extracted by press at room temperature (cold) the induction time is 15 h. whereas for the oil obtained from the same plants introduced heated, extracted by press at room temperature (cold) the induction time is 12 hours. We can deduce a better resistance to rancidity of the oil extracted by cold press from unheated plants, introduced unheated. This specificity, obviously, will have an influence on the shelf life of finished products in the dietetic, food, food supplements, cosmetics, pharmaceutical (therapeutic) and veterinary fields for human or animal use.
Les huiles ayant des propriétés de protection contre les agents génotoxiques de nature exogène (radiations ionisantes, substances chimiques ...) et/ou de nature endogène (protection contre le radical hydroxyl et l'oxygène singulet), voient leurs propriétés antioxydantes améliorées. C'est le cas de l'huile de Foraha de la famille des Clusiaceae et de l'huile de Cynara de la famille des Composeae.Oils with protective properties against genotoxic agents of an exogenous nature (ionizing radiation, chemical substances, etc.) and / or of an endogenous nature (protection against the hydroxyl radical and singlet oxygen) have their antioxidant properties improved. This is the case for Foraha oil from the Clusiaceae family and Cynara oil from the Composeae family.
Pour caractériser une molécule ou un mélange présentant des propriétés antioxydantes ou antiradicaiaires, et donc protéger une cellule humaine des dommages oxydatifs dus aux espèces oxygénées réactives (EOR) trois critères établis par Barry Halliwell doivent être pris en compte :To characterize a molecule or mixture with antioxidant or anti-radical properties, and therefore protect a human cell from oxidative damage due to reactive oxygen species (EOR) three criteria established by Barry Halliwell must be taken into account:
- La molécule doit faire la preuve qu'elle est active dans la cellule, un test purement chimique le laissera supposer mais ne le démontrera pas. - La molécule doit être efficace vis-à-vis d'un oxydant biologique, c'est-à-dire un oxydant présent dans les cellules. Certains antioxydants ont une activité protectrice spécifique contre certains oxydants.- The molecule must prove that it is active in the cell, a purely chemical test will suggest it but will not demonstrate it. - The molecule must be effective vis-à-vis a biological oxidant, that is to say an oxidant present in cells. Certain antioxidants have a specific protective activity against certain oxidants.
- Les concentrations d'oxydants utilisées doivent être compatibles avec celles utilisées in vivo. Ces remarques de Barry Halliwell, spécialiste des oxydants, sont extraites de l'article paru en 1995 dans la revue Biochemical Pharmacology (volume 49, 1341- 1348) intitulé " Antioxidant characterization - Methodology and Mechanism ". Le TEST 3D répond bien à ces différents critères : utilisation d'oxydant biologique non cytotoxique, et action des antioxydants à l'intérieur de la cellule.
Le TEST 30 permet la mise en évidence de l'effet protecteur de l'ADN par une molécule, vis-à-vis des radicaux hydroxyles générés par l'eau oxygénée, et, vis-à-vis de l'oxygène singulet généré par éclairement du bleu de méthylène. De plus, le TEST3D sur cellules répond parfaitement aux critères de Barry Halliwell. PRINCIPE DU TEST 3D- The concentrations of oxidants used must be compatible with those used in vivo. These remarks by Barry Halliwell, specialist in oxidants, are extracted from the article published in 1995 in the journal Biochemical Pharmacology (volume 49, 1341-1348) entitled "Antioxidant characterization - Methodology and Mechanism". The 3D TEST responds well to these different criteria: use of non-cytotoxic biological oxidant, and action of antioxidants inside the cell. The TEST 30 makes it possible to demonstrate the protective effect of DNA by a molecule, with respect to the hydroxyl radicals generated by hydrogen peroxide, and, with respect to the singlet oxygen generated by illumination of methylene blue. In addition, the TEST3D on cells perfectly meets the criteria of Barry Halliwell. PRINCIPLE OF THE 3D TEST
Par le développement d'un système de détection de dommages (TEST3D) sur de l'ADN capté sur microplaque (AnalytScal Biochemistry, 1995, 232, 37-42). L'ADN (devant servir de cible à des agents génotoxiques) est adsorbé sur des puits sensibilisés (schéma, étape 1), puis incubé avec des agents génotoxiques (étape 2). Les dommages engendrés sont reconnus puis réparés par les complexes protéiques spécifiques présents dans les extraits cellulaires purifiés d'origine humaine. La réparation des lésions implique une phase d'excision des lésions puis une résynthèse du fragment d'ADN ou des bases excisées. Au cours de l'étape de synthèse réparatrice, des nucléotides modifiés sont incorporés dans l'ADN (étape 3). Ces nu éotides biotinyles sont ensuite reconnus par une molécule d'avidine couplée à la peroxydase (étape 4). Un substrat chimiluminêscent de la peroxydase est ensuite ajouté et le signal émis est mesuré par un luminomètre. (étape 5). L'intensité du signal mesuré est fonction du nombre de lésions réparées sur l'ADN.By developing a damage detection system (TEST3D) on DNA captured on a microplate (AnalytScal Biochemistry, 1995, 232, 37-42). The DNA (intended to serve as a target for genotoxic agents) is adsorbed on sensitized wells (diagram, step 1), then incubated with genotoxic agents (step 2). The damage caused is recognized and then repaired by the specific protein complexes present in the purified cellular extracts of human origin. Repairing the lesions involves an excision phase of the lesions and then a resynthesis of the DNA fragment or excised bases. During the restorative synthesis step, modified nucleotides are incorporated into the DNA (step 3). These biotinyl nu eotides are then recognized by an avidin molecule coupled to peroxidase (step 4). A chemiluminous substrate for the peroxidase is then added and the signal emitted is measured by a luminometer. (step 5). The intensity of the measured signal is a function of the number of lesions repaired on the DNA.
Ce système est susceptible de réparer tous les types de lésions puisque les différentes voies de la réparation des lésions de l'ADN sont présentes et actives dans les extraits cellulaires préparés et utilisés pour cette étude. Les dommages oxydatifs sont donc reconnus dans ce système.This system is capable of repairing all types of lesions since the different ways of repairing DNA lesions are present and active in the cell extracts prepared and used for this study. Oxidative damage is therefore recognized in this system.
Ce test a permis de mettre en évidence les capacités des 20 échantillons à protéger l'ADN en utilisant des systèmes générateurs d'espèces oxygénées déjà décrits (St Cricq et al, Agri. Food Chem., 1999, 47, 425-431).This test made it possible to demonstrate the capacities of the 20 samples to protect DNA by using oxygen-generating systems already described (St Cricq et al, Agri. Food Chem., 1999, 47, 425-431).
Deux espèces oxygénées réactives ont été utilisées : l'oxygène singulet O2 et le radical hydroxyle OH°. MATERIEL ET METHODESTwo reactive oxygen species were used: singlet oxygen O2 and the hydroxyl radical OH °. MATERIAL AND METHODS
Les réactifs utilisés ont été décrits dans l'article Analytical Biochemistry, 1995.232, 37- 42,The reagents used have been described in the article Analytical Biochemistry, 1995.232, 37-42,
Le signât chimiluminêscent est détecté à l'aide d'un luminomètre Lumax2. 20 échantillons nous ont été fournis numérotés de CSB 02/01 à CSB 02/20. RESULTAT
Pour une meilleure visualisation des résultats, ceux-ci sont exprimés en pourcentage de protection ou pourcentage d'inhibition de la formation de dommages oxydatifs sur l'ADN. La valeur 0% correspond au signal de la réparation de l'ADN lésé par l'oxydant seul. Le pourcentage de protection en présence de EOR (espèces oxygénées réactives) est calculé comme la baisse relative de l'effet lésionnel dû aux radicauxThe chemiluminous sign is detected using a Lumax2 luminometer. 20 samples were provided to us numbered from CSB 02/01 to CSB 02/20. RESULT For a better visualization of the results, these are expressed as percentage of protection or percentage of inhibition of the formation of oxidative damage on DNA. The value 0% corresponds to the signal for repair of DNA damaged by the oxidant alone. The percentage of protection in the presence of EOR (reactive oxygen species) is calculated as the relative decrease in the damage effect due to radicals
OH° ou 1θ2, soit :OH ° or 1 θ2, either:
[RLU oxydant seul] - [RLU (oxydant + échantillon)][RLU oxidant only] - [RLU (oxidant + sample)]
~~ — : X 100 [RLU oxydant seul]~~ - : X 100 [RLU oxidant only]
Une inhibition non spécifique (en absence d'espèces oxygénées réactives) du signal de réparation peut être parfois observée. Ceci peut être dû à une interaction directe du composé avec l'ADN (désorption de l'ADN du puits, association non spécifique avec l'ADN qui va masquer les lésions aux protéines de réparation...). Un contrôle consistant à incuber les agents testés avec de l'ADN préalablement lésé aux UVC est donc ajouté. Une diminution du signal dans cette condition reflète une inhibition non spécifique du composé, indépendante de ses possibles propriétés. antiradicaiaires.Nonspecific inhibition (in the absence of reactive oxygen species) of the repair signal can sometimes be observed. This may be due to a direct interaction of the compound with the DNA (desorption of the DNA from the well, non-specific association with the DNA which will mask the damage to the repair proteins ...). A control consisting in incubating the agents tested with DNA previously damaged by UVC is therefore added. A decrease in signal under this condition reflects a non-specific inhibition of the compound, independent of its possible properties. antiradicaiaires.
Une inhibition de la réparation en présence de EOR peut être la conséquence - d'une réelle protection - d'une diminution de l'efficacité de la réparation d'unInhibition of repair in the presence of EOR can be the consequence - of real protection - of a reduction in the effectiveness of the repair of a
ADN endommagé dû à une interaction directe de la molécule à tester avec l'ADN ou la microplaque traitéeDamaged DNA due to direct interaction of the test molecule with the treated DNA or microplate
- de la survenue simultanée de ces 2 phénomènes. L'inhibition spécifique ou protection spécifique est égale à là différence entre l'inhibition en présence de ÉOR (espèces oxygénées réactives) et l'inhibition non spécifique. Elle est le reflet .de l'activité antiradicalaire due à la molécule seulement. RLU : Relative Light Unit ; unité arbitraire de quantité de lumière Nous constatons dans les deux TESTS suivants:- the simultaneous occurrence of these 2 phenomena. The specific inhibition or specific protection is equal to the difference between the inhibition in the presence of REE (reactive oxygen species) and the non-specific inhibition. It is a reflection of the anti-free radical activity due to the molecule only. RLU: Relative Light Unit; arbitrary unit of quantity of light We find in the following two TESTS:
Interprétation des résultats: l'échantillon 1 : Huile provenant de plantes non chauffées, introduites broyées non chauffées dans la presse, extraite à froid ou température ambiante a une meilleure activité que l'échantillon 6: Huile provenant de plantes introduites broyées chauffées dans la presse, extraite à froid ou température ambiante.Interpretation of the results: sample 1: Oil from unheated plants, introduced crushed unheated in the press, extracted cold or at room temperature has better activity than sample 6: Oil from crushed introduced plants heated in the press , extracted cold or at room temperature.
Effet sur le vieillissement cutané et plus particulièrement sur la stimulation de la synthèse du collagène du type 1.Effect on skin aging and more particularly on the stimulation of type 1 collagen synthesis.
Ces effets ont été publiés et démontrés mais nous apportons une nouveauté par le fait que les huiles obtenues par ce prbcess ont des activités nouvelles.These effects have been published and demonstrated, but we bring something new by the fact that the oils obtained by this prbcess have new activities.
L'étude a été réalisée à deux concentrations différentes sur des fibroplàstes humains. Les taux de collagène de type 1 sécrété dans le milieu d'incubation ont été mesurés par une méthode ELISA après 4 jours de culture.The study was carried out at two different concentrations on human fibroblasts. The levels of type 1 collagen secreted in the incubation medium were measured by an ELISA method after 4 days of culture.
L'effet régénérant du derme par l'hutte de FORAHA a été évalué par la mise en évidence d'une stimulation de la synthèse du collagène.The regenerating effect of the dermis by the FORAHA hut was evaluated by demonstrating stimulation of collagen synthesis.
Nous le constatons dans les résultats reportés sur le graphique A annexé.We see this in the results reported in the attached graph A.
FORAHA 1 Huile obtenue par extraction à chaudFORAHA 1 Oil obtained by hot extraction
FORAHÂ 2 Huile obtenue à partir de partie de plantes chauffées et/ou introduites à chaud, extraite à froid (T°ambiante) FORAHA 3 Huile obtenue à partir de partie de plantes non chauffées, introduites non chauffées, extraite à froid (T°ambiante)FORAHÂ 2 Oil obtained from part of heated plants and / or introduced hot, extracted cold (room temperature) FORAHA 3 Oil obtained from part of unheated plants, introduced unheated, extracted cold (room temperature) )
Résultats : on constate dans le lot traité par l'huile de Foraha obtenue par ce process une stimulation de 43% de la synthèse du collagène par rapport au témoin contre 32 et 19 % pour les huiles obtenues par les autres process. Les parties de plantes ou plantes sont cueillies, ramassées, triées, pour être immédiatement séchées. Le séchage rapide à froid afin d'obtenir un taux d'humidité
inférieur à 7% peut se faire par ventilation forcée avec de l'air dont la température est inférieure à 35° et dont le taux d'humidité est inférieur ou égal à 70%. Le séchage peut aussi s'effectuer sous vide, par micro-ondes à basse température afin de stopper les réactions enzymatiques. L'invention a pour objet l'utilisation d'huiles issues des plantes entières et/ou de parties de plantes séchées des familles citées, non chauffées, introduites broyées non chauffées dans la presse, extraites à froid sans solvant dans les compositions diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale.Results: we observe in the batch treated with Foraha oil obtained by this process a stimulation of 43% of the synthesis of collagen compared to the control against 32 and 19% for the oils obtained by the other processes. The parts of plants or plants are picked, collected, sorted, to be immediately dried. Quick cold drying to obtain a humidity level less than 7% can be done by forced ventilation with air whose temperature is below 35 ° and whose humidity is less than or equal to 70%. The drying can also be carried out under vacuum, by microwave at low temperature in order to stop the enzymatic reactions. The subject of the invention is the use of oils from whole plants and / or from parts of dried plants of the families mentioned, not heated, introduced crushed unheated in the press, cold extracted without solvent in dietetic or food compositions. , food, cosmetic, pharmaceutical (therapeutic) and veterinary supplements for human or animal use.
Ce process permet de préserver les propriétés naturelles optimales de l'huile, d'éviter la présence de résidus toxiques, d'acides gras trans.... L'usage de la presse à vis ou à cône sera privilégié. La filtration se fait par utilisation d'une centrifugeuse et/ou d'un séparateur à cônes et/ou d'un filtre poche, sous vide ou sous azote. Cette première filtration sera suivie d'une filtration sur filtres plaques, l'huile étant immédiatement conditionnée en fûts sous vide ou sous azote.This process makes it possible to preserve the optimal natural properties of the oil, to avoid the presence of toxic residues, trans fatty acids, etc. The use of the screw or cone press will be preferred. The filtration is done by using a centrifuge and / or a cone separator and / or a pocket filter, under vacuum or under nitrogen. This first filtration will be followed by filtration on plate filters, the oil being immediately packaged in barrels under vacuum or under nitrogen.
L'huile pourra subir une wintérrsation, méthode qui permet de cristalliser les composants à point d fusion élevé et de les séparer afin d'obtenir une huile brillante à basse Température,The oil may undergo a wintérrsation, a method which allows the components with a high melting point to be crystallized and separated in order to obtain a shiny oil at low temperature,
On obtient par ce process des huiles très spédfiques à chaque plante gardant leurs propriétés organoleptiques et leurs composés chimiques d'origine. Les huiles ainsi obtenues possèdent toujours des molécules différentes et plus spécialement des molécules sensibles aux températures supérieures à 48°, aux huiles obtenues selon les procédés classiques (extraction après préchauffage de parties de plantes ou plantes avant l'extraction ....). Ces molécules ont des propriétés et/ou des activités intéressantes pour lès applications diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale. Ces huiles comprennent une fraction lipidique et une fraction diteThis process produces very specific oils for each plant, retaining their organoleptic properties and their original chemical compounds. The oils thus obtained always have different molecules and more especially molecules sensitive to temperatures above 48 °, to oils obtained according to conventional methods (extraction after preheating of parts of plants or plants before extraction, etc.). These molecules have properties and / or activities of interest for dietetic, food, food supplements, cosmetics, pharmaceutical (therapeutic) and veterinary applications for human or animal use. These oils include a lipid fraction and a so-called fraction
"insaponifiable". La fraction lipidique variera selon les origines et est principalement constituée :"Unsaponifiable". The lipid fraction will vary according to the origins and is mainly composed:
- de lipides neutres entr'autres: monoacylglycérols diacylglycérols, tryacyiglycérols, stérols, stérόlesters,. hydrocarbones, - de glycotipîdes entr'autres: monogatactosyldiacyglycérol, stérolglucoside, acvlmonogalàctosyldiaglyeérol, monogaladosylmonocyglycérol,
- de phosphoiipides entr'autres : lysophosphatidylcholine, phosphatylsérine, acide phosphatidique, phosphatidylcholine,- neutral lipids among others: monoacylglycerols diacylglycerols, tryacyiglycerols, sterols, sterόlesters ,. hydrocarbons, - glycotipids among others: monogatactosyldiacyglycerol, sterolglucoside, acvlmonogalàctosyldiaglyerol, monogaladosylmonocyglycerol, - phosphoiipids among others: lysophosphatidylcholine, phosphatylserine, phosphatidic acid, phosphatidylcholine,
- et d'esters.- and esters.
La fraction dite "insaponifiable" peut comprendre différentes familles de composés, parmi lesquelles: des alcools gras, des acides, des hydrocarbures, des stérols (campestérol, stigmastérol,β sitostérol ...), des méthylstérois, des composés triterpéniques, des pro vitamine A, tocophérols, tocotriénols, des xanthophylles, des coumarines et ou des dérivés coumariniques, etc....,The so-called "unsaponifiable" fraction can include different families of compounds, including: fatty alcohols, acids, hydrocarbons, sterols (campesterol, stigmasterol, β sitosterol, etc.), methylsterois, triterpene compounds, pro-vitamins A, tocopherols, tocotrienols, xanthophylls, coumarins and or coumarin derivatives, etc.,
Les compositions selon l'invention peuvent comprendre outre des huiles telles que définies ci-dessus, des adjuvants choisis notamment parmi les corps gras, les solvants organiques, les épaississants et/ou les gélifiants, les actifs hydrophiles ou lipophiles, les adoucissants, les agents hydratants, les antioxydants, les émollients, les hydroxyacides, les opacifiants, les polymères, les propulseurs, les stabilisants, les vitamines, les réducteurs, les silicones, les parfums, les conservateurs, les charges, les séquestrants, les agents alcalinisants ou acidifiants, les agents protecteurs UV ou autres, les colorants ou d'autres extraits de plantes, ou tout autre ingrédient habituellement utilisé en formulations diététiques, alimentaires, compléments alimentaires, cosmétiques (shampooing* lotion....), pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale. Les corps gras peuvent être constitués par des huiles, des cires ou leurs mélanges, les acides gras, les alcools gras, lés esters d'acides gras, les mono, di et triglycérides d'acides grasThe compositions according to the invention can comprise, in addition to oils as defined above, adjuvants chosen in particular from fatty substances, organic solvents, thickeners and / or gelling agents, hydrophilic or lipophilic active agents, softeners, agents moisturizers, antioxidants, emollients, hydroxy acids, opacifiers, polymers, propellants, stabilizers, vitamins, reducers, silicones, perfumes, preservatives, fillers, sequestrants, alkalizing or acidifying agents, UV or other protective agents, dyes or other plant extracts, or any other ingredient usually used in dietetic, food formulations, food supplements, cosmetics (shampoo * lotion, etc.), pharmaceutical (therapeutic) and veterinary human or animal destination. The fatty substances can consist of oils, waxes or their mixtures, fatty acids, fatty alcohols, fatty acid esters, mono, di and triglycerides of fatty acids.
Bien entendu, l'homme du métier veillera à choisir le ou les éventuels composés complémentaires et/ou leur quantité de manière telle que les propriétés avantageuses attachées intrinsèquement à la composition selon l'invention, ne soient pas, ou substantiellement pas, altérées par la ou les adjonctions envisagées.Of course, those skilled in the art will take care to choose the optional additional compound (s) and / or their quantity in such a way that the advantageous properties intrinsically attached to the composition according to the invention are not, or not substantially, affected by the or the additions envisaged.
Les compositions diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale selon l'invention, peuvent contenir, outre ces huiles ci-dessus définies, toutes substances hydrophiles ou lipophiles, des pigments ou nano pigments.The dietary, food, food, cosmetic, pharmaceutical (therapeutic) and veterinary compositions for human or animal use according to the invention, may contain, in addition to these oils defined above, all hydrophilic or lipophilic substances, pigments or nano pigments.
Ces compositions peuvent se présenter en particulier sous forme d'émufsion simple ou complexe, telle qu'une crème, un lait, un gel ou un gel-crème, de poudre, de bâtonnet ou autres formes solides et éventuellement être conditionnée en aérosol et se présenter sous forme de mousse ou de spray. Elle peut être préparée sous forme d'émulsions huile-dans-eau ou eau-dans-huile.
Gertaines de ces huiles selon l'invention peuvent être également incorporées dans des émulsions alimentaires ayant la consistance de pâte à tartiner, avec des vitamines liposolubles, hydrosolubles et des oligo-éléments et toutes autres substances autorisées, pour tous objectifs. Les compositions cosmétiques, dermatologiques à destination humaine ou animale selon l'invention contiennent généralement Q,05 à 100% en poids d'huile de ces huiles.These compositions can be presented in particular in the form of a simple or complex emulsion, such as a cream, a milk, a gel or a gel-cream, powder, stick or other solid forms and optionally be packaged in aerosol and present in the form of foam or spray. It can be prepared in the form of oil-in-water or water-in-oil emulsions. Some of these oils according to the invention can also be incorporated into food emulsions having the consistency of a spread, with fat-soluble, water-soluble vitamins and trace elements and all other authorized substances, for all purposes. The cosmetic, dermatological compositions for human or animal use according to the invention generally contain 0.05 to 100% by weight of oil of these oils.
La composition selon l'invention peut également être une composition diététique alimentaire, un alicament, un complément alimentaire contenant de 0,05 à 100% en poids de telles huiles. Elle se présente alors sous forme de capsules, gélules, poudre, comprimés, gel, composés pâteux etc., et peut contenir en outre des vitamines liposolubles telles que les vitamines A, D et E, K et d'aμtres huiles.The composition according to the invention can also be a dietary food composition, a food, a food supplement containing from 0.05 to 100% by weight of such oils. It is then presented in the form of capsules, capsules, powder, tablets, gel, pasty compounds etc., and may also contain fat-soluble vitamins such as vitamins A, D and E, K and other oils.
L'inventeur a découvert en outre au cours de ses recherches que les huiles de certaines plantes des familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites selon l'invention, présentaient une activité phamαacoiogique supérieure aux huiles de ces mêmes familles extraites selon d' autres procédés. Des tests IN VIVO ont montré l'intérêt de ces huiles dans le traitement de la sécheresse, des muqueuses ( œil .. ) et dans l'amélioration des processus de cicatrisation.The inventor further discovered during his research that the oils of certain plants of the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapagaceae, Sapotaceae Simmondsiaceae, extracted according to the invention, had a phamαacoiogique activity superior to oils of these same families extracted according to other processes. IN VIVO tests have shown the interest of these oils in the treatment of dryness, mucous membranes (eye, etc.) and in the improvement of healing processes.
L'invention a donc également pour objet une composition pharmaceutique (thérapeutique) et vétérinaire à destination humaine ou animale contenant une quantité efficace de telles huiles selon l'invention, dans un support ou excipient non toxique.The invention therefore also relates to a pharmaceutical (therapeutic) and veterinary composition for human or animal use containing an effective amount of such oils according to the invention, in a non-toxic carrier or excipient.
Une telle composition peut se présenter sous forme de gélule, capsule, comprimé, liquide injectable, collyre, pommade, crème, gel, patch, suppositoire, ovule contenant de 0,05% à 100% en poids de ces huiles.Such a composition can be in the form of a capsule, capsule, tablet, injectable liquid, eye drops, ointment, cream, gel, patch, suppository, ovum containing from 0.05% to 100% by weight of these oils.
Elle peut être administrée par voie orale, locale, injectable, et en général par tout orifice naturel du corps humain ou animal, conditionnée sous des formes normales ou en libération progressive .It can be administered by oral, local, injectable route, and in general by any natural orifice of the human or animal body, conditioned in normal forms or in progressive release.
Dans l'application thérapeutique, la durée du traitement est variable suivant la gravité des symptômes et peut s'étaler entre 1 et 20 semaines, de façon continue ou discontinue et peut être renouvelée. Le traitement est déterminé par le médecin. En pratique il s'avère que les huiles extraites avec les méthodes traditionnelles et/ou par solvant présentent très souvent des risques d'irritabilité du, derme du des
muqueuses. L'inventeur a découvert aussi qu'avec les huiles obtenues par ce process, ces risques sont largement diminués.In the therapeutic application, the duration of the treatment is variable according to the severity of the symptoms and can range between 1 and 20 weeks, continuously or discontinuously and can be renewed. Treatment is determined by the doctor. In practice, it turns out that oils extracted with traditional methods and / or by solvent very often present risks of irritability of the, dermis of mucous membranes. The inventor also discovered that with the oils obtained by this process, these risks are greatly reduced.
L'invention sera mieux illustrée par les exemples ci-après.The invention will be better illustrated by the examples below.
1. Les huiles des parties de plantes des familles Anacardiaceae (Anacarde ...), Moringaceae (Moringa ..), Canabaceae (Chanvre ...), Cruciferaceae (Cameϋπe1. The oils from the parts of plants of the families Anacardiaceae (Cashew ...), Moringaceae (Moringa ..), Canabaceae (Hemp ...), Cruciferaceae (Cameϋπe
...), Curcurbitaceae (Courge ...), Linaceae (lin ...), Onagraceae (onagre ..) Saxifragaceae (Cassis ..), Simmondsiaceae (Jojoba ...), Myristicaceae (Brochoneura ..), Boraginaceae (Alkanna ...), Onagraceae (Onagre ..), Sapotaceae (Argan ...) et des Composeae (Cynara ...) ont une saveur neutre et une couleur très claire contrairement aux huiles obtenues par les méthodes traditionnelles (odeur forte, parfois de caramel). Elles n'auront pas à subir de traitement de désodorisation, décoloration qui dénature les huiles....), Curcurbitaceae (Squash ...), Linaceae (flax ...), Onagraceae (evening primrose ..) Saxifragaceae (Cassis ..), Simmondsiaceae (Jojoba ...), Myristicaceae (Brochoneura ..), Boraginaceae (Alkanna ...), Onagraceae (Evening primrose ..), Sapotaceae (Argan ...) and Composeae (Cynara ...) have a neutral flavor and a very light color unlike oils obtained by traditional methods (strong odor , sometimes caramel). They will not have to undergo deodorization treatment, discoloration which distorts the oils.
2. L'huile d'une plante de la famille des Euphorbiaceae (Aleurites): dont la composition en acides gras polyinsaturés alpha linolénique est importante, supérieure à 25% présente des caractères organoleptiques supérieurs.2. The oil of a plant of the family Euphorbiaceae (Aleurites): whose composition in polyunsaturated fatty acids alpha linolenic is important, higher than 25% presents superior organoleptic characters.
3. L'huile des plantes des familles ci-dessus citées et plus spécialement des familles Clusiaceae (Foraha), Euphorbiaceae (Aleurites), Sapotacee ( Arganier) possèdent des propriétés hydratantes, restructurantes et cicatrisantes du derme et des muqueuses supérieures aux huiles obtenues par les autres process.. 4. L'huile des plantes de la famille des Arecaceae (Palme), contient davantage de pro vitamine A et dérivés et offre un intérêt supplémentaire pour les usages diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) et vétérinaires à destination humaine ou animale.3. The oil of the plants of the families mentioned above and more especially of the families Clusiaceae (Foraha), Euphorbiaceae (Aleurites), Sapotacee (Arganier) have hydrating, restructuring and healing properties of the dermis and mucous membranes superior to the oils obtained by the other processes. 4. The oil from plants in the Arecaceae family (palm) contains more pro-vitamin A and derivatives and is of additional interest for dietetic, food, food supplements, cosmetic, pharmaceutical (therapeutic) uses. and veterinarians for human or animal use.
EXEMPLE DE FORMULATIONSEXAMPLE OF FORMULATIONS
COMPOSITION DIETETIQUE EXEMPLE 1DIETETIC COMPOSITION EXAMPLE 1
Gélules d'huile végétale 610 mg (+/-1%) comprenantVegetable oil capsules 610 mg (+/- 1%) including
• Huile de Ribes nîgrum et d'Aleurites moluccana 463mg• Ribes nîgrum and Aleurites moluccana oil 463mg
• Cire d'abeille 45 mg• Beeswax 45 mg
• Vitamine E 3 mg • Excipients 99 g (gélule végétale cellulose )
COMPOSITIONS COSMETIQUES• Vitamin E 3 mg • Excipients 99 g (vegetable cellulose capsule) COSMETIC COMPOSITIONS
EXEMPLE 2EXAMPLE 2
LAIT APRES SOLEIL, APAISANT et RESTRUCTURANTAFTER SUN MILK, SOOTHING AND RESTRUCTURING
Nom commercial Nomenclature INCI ou latinTrade name INCI or Latin nomenclature
PHASE 1PHASE 1
Aqua Aqua qqsAqua Aqua some
Montanov L C14-22 alkylalcohol and C12-20 alkylglucoside 3 Montane 80 VG Sorbitan monooléate 1,5Montanov L C14-22 alkylalcohol and C12-20 alkylglucoside 3 Montane 80 VG Sorbitan monooleate 1.5
PHASE 2PHASE 2
Huile de Bakoly Aleurites moluccana seed oil (famille euphorbiacae) 10 Huile de Jojoba oïl Simmondsla chinensis seed oil (famille 5 sim ondiaceae)Bakoly oil Aleurites moluccana seed oil (family euphorbiacae) 10 Jojoba oil oïl Simmondsla chinensis seed oil (family 5 sim ondiaceae)
PHASE 3PHASE 3
Fragance Perfume 0.3 Sepicide HB Phenoxyethanol : Methyl, propyl-, ethyl-, butylparaben 0,3Fragrance Perfume 0.3 Sepicide HB Phenoxyethanol: Methyl, propyl-, ethyl-, butylparaben 0.3
EXEMPLE 3EXAMPLE 3
SPRAY, APAISANT et hydratantSPRAY, SOOTHING and hydrating
Nom commercial Nomenclature INCI ou latinTrade name INCI or Latin nomenclature
PHASE 1PHASE 1
Aqua Aqua qqs Xyliance Cetearyl wheat straw glycosides, Cetearyl alcohol 0,5Aqua Aqua qqs Xyliance Cetearyl wheat straw glycosides, Cetearyl alcohol 0,5
PHASE 2PHASE 2
Huile de Bakoly Aleurites moluccana seed oil (famille euphorbiacae) 10 Huile de Argan Argania spinosa seed oil (famille sapotacées) 5 Huile de Jojoba Simmondsia chinensis seed oil 2,5 (famille simmondiaceae)Bakoly oil Aleurites moluccana seed oil (family euphorbiacae) 10 Argan oil Argania spinosa seed oil (family sapotaceae) 5 Jojoba oil Simmondsia chinensis seed oil 2,5 (family simmondiaceae)
PHASE 3PHASE 3
Fragance 0,3 Sepicide HB Phenoxyethanol : Methyl, propyl-, ethyl-, butylparaben 0,3 Sepicide Cl Imidazolidinyl urea 0,2Fragrance 0.3 Sepicide HB Phenoxyethanol: Methyl, propyl-, ethyl-, butylparaben 0.3 Sepicide Cl Imidazolidinyl urea 0.2
PROTOCOLE valable pour toutes les formules COSMETIQUES et THERAPEUTIQUESPROTOCOL valid for all COSMETICS and THERAPEUTICS formulas
Phase 1 Chauffer au bain marie à 70° tout en agitant, bien faire fondre te tensio actif.Phase 1 Heat in a water bath to 70 ° while stirring, melt the surfactant well.
Phase 2 Laisser refroidir, introduire les ingrédients, agiter fortement.Phase 2 Let cool, introduce the ingredients, shake vigorously.
Phase 3 Introduire, agiter quelques minutes.
COMPOSITIONS J[ΗERAPEUTIOUESPhase 3 Introduce, shake a few minutes. COMPOSITIONS J [APEERAPEUTIOUES
EXEMPLE 4 CREME BRULUREEXAMPLE 4 CREAM BURNING
PHASE 1 Aqua purifée Aqua qqsPHASE 1 Aqua purified Aqua qqs
Montanox 80 VG PHA Polysorbate 80 2,5 - 3 Montane 80 PHA Sorbitan monooléate 2,5 - 3Montanox 80 VG PHA Polysorbate 80 2.5 - 3 Montane 80 PHA Sorbitan monooleate 2.5 - 3
PHASE 2PHASE 2
Huile de Foraha Foraha seed oil (Clusiaceae) 15 Huile de Jojoba Simmondsia chinensis seed oil (famille 5 simmondiaceae)Oil of Foraha Foraha seed oil (Clusiaceae) 15 Oil of Jojoba Simmondsia chinensis seed oil (family 5 simmondiaceae)
Huile de Bakoly Aleurites moluccana seed oil (famille euphorbiacae) 5Bakoly oil Aleurites moluccana seed oil (family euphorbiacae) 5
PHASE 3PHASE 3
Vitamine E Alpha tocophérol 0.3 Conservateur Conservateur 0,3Vitamin E Alpha tocopherol 0.3 Conservative Conservative 0.3
EXEMPLE 5EXAMPLE 5
CREME maux de gorge, sinusiteCREAM sore throat, sinusitis
PHASE 1 Aqua purifée Aqua qqsPHASE 1 Aqua purified Aqua qqs
Montanov 68 PHA Cetearyl alcohol cetearyl glucuside 5Montanov 68 PHA Cetearyl alcohol cetearyl glucuside 5
PHASE 2PHASE 2
Huile de Rara Brochoneura acuminata seed oil (Myristicaceae) 15 Huile de Bakoly Aleurites moluccana seed oil (famille euphorbiacae) 5Rara Brochoneura acuminata seed oil (Myristicaceae) 15 Bakoly oil Aleurites moluccana seed oil (family euphorbiacae) 5
PHASE 3PHASE 3
Vitamine E Alpha tocophérol 0.3 HE Faux Essential oil Cinnamomum camphora Madagascar 0,5 Camphrier Conservateur Conservateur 0,3Vitamin E Alpha tocopherol 0.3 HE False Essential oil Cinnamomum camphora Madagascar 0.5 Camphor tree Conservative Conservative 0.3
EXEMPLE 6EXAMPLE 6
COLLYREEYE DROPS
PHASE 1 Aqua purifée PPt Aqua qqs Montanov 68 PHA Cetearyl/alcolol/cetearyl/glucosyde 0,5PHASE 1 Aqua purified PPt Aqua qqs Montanov 68 PHA Cetearyl / alcolol / cetearyl / glucosyde 0.5
PHASE 2 Huile de Foraha Foraha seed oil (Clusiaceae) 2 Vitamine E Tocophérol 0,05 à 0,1PHASE 2 Foraha Oil Foraha seed oil (Clusiaceae) 2 Vitamin E Tocopherol 0.05 to 0.1
PHASE 3PHASE 3
Ciclosporin 0,1 à 2 Conservateur Conservateur 0,3
Ciclosporin 0.1 to 2 Preservative Preservative 0.3
Claims
1. Composition diététiques, alimentaires, compléments alimentaires, cosmétiques, pharmaceutiques (thérapeutiques) destinée à usage vétérinaire et humain comprenant une huile ou un mélange d'huiles provenant de plantes ou parties de plantes non chauffées, introduites broyées non chauffées dans la presse, issues des familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites à froid et filtrées immédiatement après extraction, la composition chimique de telles huiles comprend des molécules sensibles aux températures supérieures à 48°.1. Dietetic, food, food, cosmetic, pharmaceutical (therapeutic) compositions intended for veterinary and human use comprising an oil or a mixture of oils coming from unheated plants or parts of plants, introduced crushed unheated in the press, from of the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, cold extracts and extracts, chemical extracts and extracts after cold extracts molecules sensitive to temperatures above 48 °.
2. Utilisation d'huile ou d'un mélange d'huiles provenant de plantes ou parties de plantes non chauffées, introduites J royées non chauffées dans la presse, des familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites à froid et filtrées immédiatement après extraction, par suite d'une résistance au rancissement supérieure aux huiles extraites selon les autres procédés, pour la préparation d'une composition alimentaire, diététique, cosmétique (dont parfumerie), pharmaceutique (thérapeutique) destinée à usage vétérinaire et humain.2. Use of oil or a mixture of oils from unheated plants or parts of plants, introduced into the unheated royal presses, from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae , Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted and filtered immediately after extraction, due to superior rancidity to oils extracted by other methods, for the preparation of a composition food, dietetics, cosmetics (including perfumery), pharmaceutical (therapeutic) intended for veterinary and human use.
3. Utilisation d'huile ou d'un mélange d'huiles provenant de plantes ou parties de plantes non chauffées, introduites broyées non chauffées dans la presse, des familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, extraites à froid et filtrées immédiatement après extraction en tant qu'agent intervenant dans l'amélioration de la sécheresse de la peau et des muqueuses (vaginale, œil), pour la préparation d'une composition pharmaceutique (thérapeutique) destinée à usage vétérinaire et humain.3. Use of oil or a mixture of oils from unheated plants or parts of plants, introduced crushed unheated in the press, from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae, Sapotaceae, Saxifragaceae, Simmondsiaceae, cold extracted and filtered immediately after extraction as an agent intervening in the improvement of the dryness of the skin and mucous membranes (vaginal, eye), for the preparation of a pharmaceutical (therapeutic) composition intended for veterinary and human use.
4. Utilisation d'huile ou d'un mélange d'huiles provenant de plantes ou parties de plantes non chauffées, introduites broyées non chauffées dans la presse, des familles Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae Sapotaceae, Saxifragaceae Simmondsiaceae, extraites à froid et filtrées immédiatement après extraction en tant qu 'agent restructurant et favorisant une meilleure cicatrisation pour la préparation d'une composition pharmaceutique (thérapeutique) destinée à usage vétérinaire et humain.4. Use of oil or a mixture of oils from unheated plants or parts of plants, introduced crushed unheated in the press, from the families Anacardiaceae, Arecaceae, Boraginaceae, Canabaceae, Clusiaceae, Composeae, Cruciferaceae, Curcurbitaceae, Euphorbiaceae, Linaceae, Moringaceae, Myristicaceae, Onagraceae Sapotaceae, Saxifragaceae Simmondsiaceae, cold extracted and filtered immediately after extraction as a restructuring agent and promoting better healing for the preparation of a pharmaceutical (therapeutic) composition intended for veterinary and human use.
5. Composition alimentaire, diététique, cosmétique (dont parfumerie), pharmaceutique (thérapeutique), destinée à usage vétérinaire et humain telle que décrite dans l'une des revendications 1 et 4, caractérisée par le fait qu'elle comprend en outre au moins un adjuvant choisi parmi les corps gras, les solvants organiques, les épaississants et/ou les gélifiants, les actifs hydrophiles ou lipophiles, les adoucissants, les agents hydratants, les antioxydants, émollients, les hydroxyacides, les opacifiants, les polymères, les propulseurs, les stabilisants, les vitamines, les réducteurs, les silicones, les parfums, les conservateurs, les charges, les séquestrants, les agents alcalinisants ou acidifiants, les agents protecteurs UV ou autres, les colorants, des extraits de plantes ou tout autre ingrédient.5. Food, dietetic, cosmetic (including perfumery), pharmaceutical (therapeutic) composition, intended for veterinary and human use as described in one of claims 1 and 4, characterized in that it also comprises at least one adjuvant chosen from fatty substances, organic solvents, thickeners and / or gelling agents, hydrophilic or lipophilic active agents, softeners, hydrating agents, antioxidants, emollients, hydroxy acids, opacifiers, polymers, propellants, stabilizers, vitamins, reducers, silicones, perfumes, preservatives, fillers, sequestrants, basifying or acidifying agents, UV or other protective agents, dyes, plant extracts or any other ingredient.
6. Compositions cosmétiques (dont parfumerie, fragrance), ou dermatologiques à destination humaine et animale, selon la revendication 5, caractérisées par le fait qu'elles se présentent sous forme solide, liquide ou pâteuse, tel qu'un shampooing, une émulsion, une dispersion, une lotion, une huile, une poudre, une mousse, un spray, un bâtonnet solide ou un patch.6. Cosmetic (including perfumery, fragrance) or dermatological compositions for human and animal use, according to claim 5, characterized in that they are in solid, liquid or pasty form, such as a shampoo, an emulsion, a dispersion, a lotion, an oil, a powder, a foam, a spray, a solid stick or a patch.
7. Compositions cosmétiques (dont parfumerie, fragrance), dermatologiques à destination humaine ou animale selon la revendication 5, caractérisée par le fait qu'elles contiennent 0,05 à 100% en poids de telles huiles.7. Cosmetic (including perfumery, fragrance), dermatological compositions for human or animal use according to claim 5, characterized in that they contain 0.05 to 100% by weight of such oils.
8. Compositions alimentaires, diététiques, compléments alimentaires à destination humaine et animale selon la revendication 5, caractérisées par le fait qu'elles se présentent sous forme d'huile, d'émulsion, de dispersion, de gélules, de capsules ou de comprimés.8. Food, dietetic compositions, food supplements for human and animal use according to claim 5, characterized in that they are in the form of oil, emulsion, dispersion, capsules, capsules or tablets.
9. Compositions alimentaires, diététiques, compléments alimentaires à destination humaine ou animale selon les revendications 8, caractérisées en ce qu'elles contiennent 0,05 à 100% en poids de telles huiles.9. Food, dietetic compositions, food supplements for human or animal use according to claims 8, characterized in that they contain 0.05 to 100% by weight of such oils.
10. Compositions pharmaceutiques (thérapeutique), vétérinaires selon la revendication 5, caractérisées en ce qu'elles se présentent sous forme de gélules, capsules, patchs, comprimés, suppositoires, ovules, crèmes, gels ou liquides injectables.10. Pharmaceutical (therapeutic), veterinary compositions according to claim 5, characterized in that they are presented under capsules, capsules, patches, tablets, suppositories, eggs, creams, gels or injectable liquids.
11. Compositions pharmaceutiques (thérapeutique), vétérinaires selon la revendication 10 caractérisées en ce qu'elles contiennent 0,05 à 100% en poids de telles huiles.11. Pharmaceutical (therapeutic), veterinary compositions according to claim 10 characterized in that they contain 0.05 to 100% by weight of such oils.
12. Procédé d'obtention d'une composition selon les revendications 5 à 11 , caractérisé en ce que l'huile utilisée est obtenue à partir de plantes ou parties de plantes non chauffées, introduites broyées non chauffées dans la presse, extraites à froid et filtrées immédiatement après extraction.12. Method for obtaining a composition according to claims 5 to 11, characterized in that the oil used is obtained from unheated plants or parts of plants, introduced crushed unheated in the press, cold extracted and filtered immediately after extraction.
13. Procédé d'obtention d'une composition selon la revendication 12, caractérisé par le fait que les plantes ou parties de plantes sont cueillies ou ramassées, triées pour être immédiatement séchées à froid par ventilation forcée avec de l'air dont la température est inférieur à 35° et à un taux d'humidité égale ou inférieur à 70%, le séchage peut aussi s'effectuer sous vide, par micro-ondes mais toujours à basse température, les plantes ou parties de plantes non chauffées sont ensuite introduites broyées, non chauffées dans la presse, extraites à froid sans solvant. 13. A method of obtaining a composition according to claim 12, characterized in that the plants or parts of plants are picked or picked, sorted to be immediately cold dried by forced ventilation with air whose temperature is lower than 35 ° and at a humidity level equal to or lower than 70%, drying can also be carried out under vacuum, by microwave but always at low temperature, the plants or parts of plants not heated are then introduced crushed , not heated in the press, cold extracted without solvent.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0214723A FR2847476B1 (en) | 2002-11-25 | 2002-11-25 | USE OF OILS OBTAINED FROM PARTS OF NON-HEATED PLANTS, INTRODUCED NOT HEATED MILLED IN THE PRESS, COLD EXTRACTED IN THE COMPOSITIONS |
| FR0214723 | 2002-11-25 | ||
| PCT/FR2003/003338 WO2004050108A1 (en) | 2002-11-25 | 2003-11-07 | Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1601369A1 true EP1601369A1 (en) | 2005-12-07 |
Family
ID=32241562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP03789462A Withdrawn EP1601369A1 (en) | 2002-11-25 | 2003-11-07 | Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressing |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1601369A1 (en) |
| AU (1) | AU2003294047A1 (en) |
| FR (1) | FR2847476B1 (en) |
| WO (1) | WO2004050108A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2886547B1 (en) * | 2005-06-02 | 2009-06-05 | Boucher Claude Henri Marie Ghi | COSMETIC, DIETETIC, PHARMACEUTICAL COMPOSITION OBTAINED FROM NON-REFINED OIL FREE OF TRANS FATTY ACIDS, PHORBOLIC ESTERS, SOLVENT-FREE EXTRACT |
| DE102006018448A1 (en) * | 2006-04-19 | 2007-10-25 | Schröder, Jan | Delicious liquid feed as beverages for the animals, races and subspecies of the animals e.g. fish, dog, horses, snakes, milk cattle and pigeons, comprises a freeze- or spray dried camelina oil, and feed preparation or ready food |
| EP2025242A1 (en) * | 2007-07-25 | 2009-02-18 | Universität Hohenheim | Feed and feed additive for herbivores, and method for manufacturing the same |
| CN105816498A (en) | 2009-04-27 | 2016-08-03 | 玫琳凯有限公司 | Botanical anti-acne formulations |
| FR2958163B1 (en) * | 2010-03-31 | 2014-06-13 | Fabre Pierre Dermo Cosmetique | PREPARATION FROM IN VITRO CULTURE OF NON-ELICITED ARGANIER DIFFERENTIAL CELLS, USE THEREOF FOR THE TREATMENT OF SKIN AGING, INFLAMMATION AND HEALING, AND OBTAINING THEM. |
| US9138401B2 (en) | 2011-12-19 | 2015-09-22 | Mary Kay Inc. | Combination of plant extracts to improve skin tone |
| FR3013594B1 (en) * | 2013-11-25 | 2017-11-10 | Basf Beauty Care Solutions France Sas | COSMETIC OR DERMATOLOGICAL USE OF A MOLUCCANA ALEURITES EXTRACT |
| EP3116469B1 (en) | 2014-03-10 | 2018-10-03 | Mary Kay, Inc. | Skin lightening compositions |
| KR102346724B1 (en) * | 2018-05-23 | 2022-01-04 | 한국식품연구원 | Composition for improving asthma or chronic obstructive pulmonary disease using an extract of Epilobium pyrricholophum |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1387163A (en) * | 1972-08-25 | 1975-03-12 | Rose Downs & Thompson Ltd | Extraction of oil from oilcontaining organic material |
| US4352797A (en) * | 1981-07-02 | 1982-10-05 | Wofor Ag | Biologically active extracts from Myristica castaneifolia (Myristicaceae) Fiji and a method of obtaining same |
| EP0092076B1 (en) * | 1982-04-16 | 1986-12-17 | Societe Des Produits Nestle S.A. | Lipid composition for oral, enteral or parenteral feeding |
| FR2565789B1 (en) * | 1984-06-15 | 1990-07-06 | Univ Toronto Innovation Found | PROCESS FOR THE SOLVENT TREATMENT OF PROTEIN MATERIALS FROM CRUCIFER OLEAGINOUS SEEDS TO OBTAIN PROTEIN FLOUR WITH REDUCED GLUCOSINOLATE CONTENT |
| DE3907427A1 (en) * | 1989-03-08 | 1990-09-13 | Suwelack Nachf Dr Otto | Process for gentle preparation of plant extracts |
| GB2271928A (en) * | 1992-10-27 | 1994-05-04 | Rose Mary Elizabeth Laing | Borage plant extracts |
| FR2756183B1 (en) * | 1996-11-25 | 1999-08-27 | Fabre Pierre Dermo Cosmetique | COMBINATION OF OIL AND ARGAN PEPTIDES USEFUL FOR THE TREATMENT OF SKIN AGING-RELATED DISORDERS |
| BE1010945A6 (en) * | 1997-02-25 | 1999-03-02 | Claude Boucher | VEGETABLE OIL EXTRACTED PLANT OF THE GENUS "Calophyllum FILTER AND PROTECTIVE ULTRA VIOLET RAYS. |
| BE1011858A7 (en) * | 1998-04-01 | 2000-02-01 | Raquet Jean Paul | Phytocosmetic and phytodermatological external body care product production method |
| FR2794973B1 (en) * | 1999-06-18 | 2001-09-14 | Mousny Brigitte | USE OF OIL FROM PLANTS OF THE CALOPHYLLUM TYPE EXTRACTED AT AMBIENT TEMPERATURE IN COSMETIC, DIETETIC AND THERAPEUTIC COMPOSITIONS |
| AU5425999A (en) * | 1999-08-26 | 2001-03-19 | Jean Julia | Dietetic use of cynara cardunculus and silybum marianum oils |
| FR2804023B1 (en) * | 2000-01-26 | 2002-09-20 | Johnson & Johnson Consumer Fr | NUTRITIONAL SUPPLEMENT BASED ON CASSIS OIL |
| DE10041700A1 (en) * | 2000-08-24 | 2002-03-14 | Mathilde Wiest | Agent for control of skin irritations and for promotion of wound healing based on cold pressed hemp seed oil |
-
2002
- 2002-11-25 FR FR0214723A patent/FR2847476B1/en not_active Expired - Fee Related
-
2003
- 2003-11-07 EP EP03789462A patent/EP1601369A1/en not_active Withdrawn
- 2003-11-07 WO PCT/FR2003/003338 patent/WO2004050108A1/en not_active Ceased
- 2003-11-07 AU AU2003294047A patent/AU2003294047A1/en not_active Abandoned
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2004050108A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004050108A1 (en) | 2004-06-17 |
| AU2003294047A1 (en) | 2004-06-23 |
| FR2847476B1 (en) | 2006-03-24 |
| FR2847476A1 (en) | 2004-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0914090B1 (en) | Antioxidant and/or antielastase dermatological composition based on lupine oil | |
| EP0512040B1 (en) | Cosmetic compositions containing an essence of sunflower oil cake (helianthus annuus) | |
| EP4099975A1 (en) | Method for obtaining an aqueous extract of lavender, compositions comprising such an extract and their cosmetic uses | |
| FR3045380B1 (en) | EXTRACT OF PASSIFLORE SEEDS AND COSMETIC, PHARMACEUTICAL OR DERMATOLOGICAL COMPOSITIONS COMPRISING SAME. | |
| WO2017077497A1 (en) | Synergistic extract of palmaria palmata and of jasmine, compositions comprising same and uses thereof | |
| EP0581624A1 (en) | Cosmetic or food composition containing a fraction of unsaponifiabler of hot oil and a vitamin-E | |
| EP1601369A1 (en) | Oil compositions obtained from non-heated plant parts, introduced ground and non-heated in the press, extracted by cold pressing | |
| FR2822381A1 (en) | New superoxide dismutase compositions, used for e.g. prevention and treatment allergies, inflammatory disorders, and degenerative disorders, comprise Cucumis melo extract and a liposoluble fatty material | |
| EP3917554B1 (en) | Method for obtaining an extract of patchouli leaves and cosmetic uses thereof | |
| EP3980123A1 (en) | Moringa peregrina seed extract rich in 2,5-diformylfuran, process for obtaining same and use thereof in cosmetic compositions | |
| CA2636114A1 (en) | Use of an unsaponifiable extract of plant pulp in the treatment of skin ageing | |
| FR2794973A1 (en) | Calophyllum oil extracted at ambient temperature has UV protecting, antiradical, antioxidant, antiaging and therapeutic properties | |
| EP4380590B1 (en) | Composition based on crocus sativus and cannabis sativa | |
| EP2683392B1 (en) | Cinnamomum burmanii extract, extraction process and its use as proton pump down-regulator, enzyme inhibitor, and mucoprotector | |
| FR2858982A1 (en) | Preparing plant oil by solvent-less pressing of powdered material, useful in e.g. cosmetic, food, pharmaceutical and agricultural compositions, gives product with improved oxidation resistance | |
| FR3049864A1 (en) | VEGETABLE EXTRACT FROM A PLANT OF THE GENUS AERVA, COMPOSITION CONTAINING SAME AND USE OF SAID VEGETABLE EXTRACT | |
| FR2886547A1 (en) | Composition, useful to prepare drug that is useful in e.g. dermatology, hepatology and urology, comprises oil or mixture of cold extracted oils, ambient temperature oils or solvent-free oils of terrestrial/marine plants or plant parts | |
| FR2888509A1 (en) | EXTRACTS FROM GINKGO BILOBA | |
| FR2799122A1 (en) | Vegetable lipid complex, used to hydrate and restructure skin, comprises sphingolipids, glycoceramides, sterols, essential fatty acids, phospholipids and glycolipids | |
| FR3019987A1 (en) | COSMETIC COMPOSITION COMPRISING A MIXTURE OF HONEY AND KNIPHOFIA NECTAR | |
| FR3110419A1 (en) | Moringa peregrina seed extract rich in 2,5-diformylfuran, process for obtaining it and its use in cosmetic compositions | |
| OA21067A (en) | Moringa Peregrina seed extract rich in 2,5-diformylfuran, its process for obtaining it and its use in cosmetic compositions. | |
| FR3150947A1 (en) | DAMASCUS ROSE extract rich in polyphenols OBTAINED from a co-product of HYDROdistillation AND ITS USES as a food supplement | |
| FR2878744A1 (en) | Production of fenugreek oil, for use in e.g. cosmetology, comprises dehulling and crushing to isolate, and extracting by flaking, crushing, removal of solvent, purifying and neutralizing and washing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20050927 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MOLUCAL SAS |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20080327 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20080807 |